Länder Analysen: Schweiz
| 21.04.22 | UBS Underweight | Barclays Capital | |
| 21.04.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 20.04.22 | DocMorris Sell | UBS AG | |
| 20.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Sell | UBS AG | |
| 12.04.22 | DocMorris Sell | UBS AG | |
| 12.04.22 | Givaudan Underweight | Barclays Capital | |
| 12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 11.04.22 | DocMorris Sell | UBS AG | |
| 07.04.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 07.04.22 | Swiss Re Sell | UBS AG | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 31.03.22 | DocMorris Sell | UBS AG | |
| 29.03.22 | DocMorris Sell | UBS AG | |
| 28.03.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 23.03.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 16.03.22 | Swiss Re Sell | UBS AG | |
| 14.03.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 11.03.22 | DocMorris Sell | UBS AG | |
| 03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.03.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 25.02.22 | Swiss Re Sell | UBS AG | |
| 17.02.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 14.02.22 | DocMorris Sell | UBS AG | |
| 14.02.22 | UBS Hold | HSBC | |
| 11.02.22 | UBS Underweight | Barclays Capital | |
| 11.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 10.02.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 10.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 08.02.22 | Swiss Re Underweight | Morgan Stanley | |
| 04.02.22 | Holcim Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.02.22 | Novartis Sell | Deutsche Bank AG | |
| 03.02.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 02.02.22 | DocMorris Sell | UBS AG | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | Barclays Capital | |
| 31.01.22 | Givaudan Underweight | Barclays Capital | |
| 31.01.22 | Givaudan Underperform | Credit Suisse Group | |
| 28.01.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 28.01.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 28.01.22 | Givaudan Underperform | Bernstein Research | |
| 27.01.22 | Swiss Re Sell | UBS AG | |
| 26.01.22 | UBS Underweight | Barclays Capital | |